Stem cell marker |
|
PTPRN2 |
Protein tyrosine phosphatase, receptor type, N polypeptide 2 |
ALDH1(A1) |
Aldehyde dehyfrogenase 1 family, member A1; involved in metabolism |
CD44 |
CD44 antigen; involved in cell-cell interaction, cell adhesion and migration |
PTEN |
Phosphatase and tensin homolog; tumor suppressor. Acts as a dual-specificity protein phosphatase. |
CD133 (PROM1) |
Prominin 1; binds cholesterol in cholesterol-containing plasma membrane microdomains |
NKX3-1 |
NK3 homeobox 1; transcription factor, acts as tumor suppressor controlling prostate carcinogenesis |
MYC |
V-myc avian myelocytomatosis viral oncogene homolog; activate the transcription of growth-related genes |
ATXN1 (SCA-1) |
Ataxin 1; chromatin-binding factor that repress Notch signaling |
GATA3 |
GATA binding protein 3; transcription factor contains two GATA-type zinc fingers |
TNFSF11 (RANKL) |
Tumor necrosis receptor (ligand) superfamily, member 11; ligand of cytokine |
TNFRSF11B |
Tumor necrosis receptor superfamily, member 11b; acts as decoy receptor in osteroclastogenesis. |
TACSTD2 |
Tumor-associated calcium signal transducer 2; A cell surface receptor that transduces calcium signals. |
Other EMT-related genes |
|
CXCL13 |
Chemokine (C-X-C motif) ligand 13; chemotactic for B-lymphocytes |
ESR2 (ESRb) |
Estrogen receptor 2 (ER beta); nuclear receptor transcription factors |
ASPA |
Aspartoacylase; catalyzes the conversion of N-acetyl_L-aspartic acid to aspartate and acetate |
CDH2 |
Cadherin 2; cadherin, neuronal (N-cadherin); a calcium dependent cell-cell adhesion glycoprotein; contribute to the sorting of heterogeneous cell types |
CDH1 |
Cadherin 1; E-cadherin (epithelial); a calcium dependent cell-cell adhesion glycoprotein; loss of funtion contribute to progression of several cancers. |
COL1A2 |
Collagen, type 1, alpha 2; a type-I fibril-forming collagen |
DAB2IP |
DAB2 interacting protein; functions as a Ras GTPase-activating protein. |
FN1 |
Fibronectin 1; involved in cell adhsion and migration processes |
VIM |
Vimentin; Class-III intermediate filaments found in non-epithelial cells, especially mesenchymal |
ITGB1 (CD29) |
Integrin, beta 1; membrane receptors involved in cell adhesion and recognition |
Wnt signaling |
|
IGF1 |
Insulin-like growth factor (somatomedin C); growth promoting by enhancing glucose uptake |
IGF2 |
Insulin-like growth facotr 2 (somatomedin A); growth-promoting activity |
WNT5A |
Wingless-type MMTV integration site family, member 5A |
IGF1R |
Insulin-like growth factor 1 receptor |
FZD4 |
Frizzled family receptor 4 |
WNT11 |
Wingless-type MMTV integration site family, member 11 |
MMP14 |
Matrix metallopeptidase 14 (membrane-inserted) |
MMP9 |
Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
WNT5B |
Wingless-type MMTV integration site family, member 5B |
SNAI2 |
Slug; Snail, drosophila, homolog of, 2 |
GSK3B |
Glycogen synthase kinase 3 beta |
MMP2 |
Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
MMP7 |
Matrix metallopeptidase 7 (matrilysin, uterine) |
NOTCH1 |
Notch, drosophila, homolog of, 1; translocation-associated notch homolog (TAN1) |
SOX9 |
SRY (sex determining region Y)-box 9 |
TCF3 |
Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) |
CTNNB1 |
Catenin, beta-1; cadherin-associated protein, beta; beta-catenin |
FZD7 |
Frizzled family receptor 7 |
ITGA6 |
Integrin, alpha 6 |
SHH signaling |
|
PTCH1 |
Patched 1 |
GLI-3 |
GLI family zinc finger 3 |
PTCH2 |
Patched 2 |
SHH |
Sonic hedgehog |
TGFβ signaling
|
|
FOXP3 |
Forkhead box P3 |
TGFB3 |
Transforming growth factor, beta 3 |
SMAD2 |
SMAD family member 2 |
TWIST1 |
Twist, drosophila, homolog of 1 |
ZEB1 |
Zinc finger E-box binding homeobox 1 |
BMP7 |
Bone morphogenetic protein 7 |
TGFB2 |
Transforming growth factor, beta 2 |
ZEB2 |
Zinc finger E box-binding homeobox 2; SMAD-interacting protein 1 (SMADIP1) |
FOXC2 |
Forkhead box C2 (MFH-1, mesenchyme forkhead 1) |
FOXA2 |
Forkhead box A2 |
TGFB1 |
Transforming growth factor, beta 1 |
EGFR signaling |
|
EGFR (Her/ERBB1) |
Epidermal growth factor receptor; HER1; ERBB1 |
ERBB2 |
V-ERB-B2 avian erythroblastic leukemia viral oncogene homolog 2; NEU; HER2 |
SRC |
proto-oncogene tyrosine-protein kinase SRC |
Clinical drug targets |
|
PIM3 |
Pim-3 oncogene |
MTOR |
Mechanistic target of rapamycin (serine/threonine kinase) |
ACP5 |
Acid phosphatase 5, tartrate resistant |
PIM1 |
Pim-1 oncogene |
PIM2 |
Pim-2 oncogene |
AXL |
AXL receptor tyrosine kinase |
ALPL (BAP) |
Alkaline phosphatase, liver/bone/kidney |
SPP1 |
Secreted phosphoprotein 1 |
ADRA2A |
Adrenergic, alpha-2A-, receptor |
HERPUD1 (MIF1) |
Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
AURKA |
Aurora kinase A |
MUC1 |
Mucin 1, transmembrane |
Prostate markers |
|
EpCAM |
Epithelial cell adhesion molecule |
ACPP (PSAP) |
Acid phosphatase, prostate |
MKI67 (Ki-67) |
Antigen identified by monoclonal antibody Ki-67 |
KLK4 |
Kallikrein-related peptidase 4 |
PCA-3 |
Prostate cancer antigen 3 (non-protein coding) |
FOLH1 (PSMA) |
Folate hydrolase (prostate-specific membrane antigen) 1 |
KLK2 |
Kallikrein-related peptidase 2 |
KRT5(CK5) |
Keratin 5 |
KRT7(CK7) |
Keratin 7 |
KRT8(CK8) |
Keratin 8; cytokeratin 8 |
PSA (KLK3) |
Kallikrein-related peptidase 3 |
Controls |
|
PTPRC (CD45) |
Leukocyte-common antigen; protein-tyrosine phosphatase, receptor-type, c |
UBB |
Ubiquitin B; polyubiquitin B |